<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01375855</url>
  </required_header>
  <id_info>
    <org_study_id>2007-000142-12</org_study_id>
    <nct_id>NCT01375855</nct_id>
  </id_info>
  <brief_title>Late Incomplete Stent Apposition Evaluation II: Comparison Between Polimer-based and No-polimer Stent System. IVUS Based Study</brief_title>
  <acronym>LISAII</acronym>
  <official_title>Late Incomplete Stent Apposition Evaluation II: Vascular Effects Evaluation After Polimer and No-polimer Based Coronary Artery Drug Eluting Stent Ilmplantation. An IVUS Based Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vascular effects evaluation after non-polimeric and polimeric paclitaxel stent
      implantation.In particular the investigators will use Taxus )as a polimeric stent)and Axxion
      (as a non-polimeirc)stent system. The investigators will look at late stent malapposition by
      means of intracoronary ultrasound imaging technique (IVUS) at baseline and 9 months
      follow-up. The investigators sought to compare the two stent types with the same drug to
      verify the polimer role. The polimer itself seems to provoke inflammation and
      hypersensibility if the arterial wall and it seems to be the base of a process of positive
      remodeling found at drug eluting stent implantation site.

      This positive remodeling is the mechanism producing late stent malapposition which on its
      turn can determine stent thrombosis, as demonstrated by pathological studies. At the same
      time the investigators will study the incidence of clinical events like myocardial
      infarction, stent thrombosis, TLR and death along with the incidence of angiographic
      restenosis at 2 years follow up.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2007</start_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intra coronary ultrasound analysis to verify stent malapposition at follow-up</measure>
    <time_frame>9 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical events (myocardial infarction, TLR,at 1, 9, 12, 24 months follow-up:; Incidence of restenosis with QCA at 9 months follow-up Intimal hiperplasia measured by IVUS at 9 months follow-up; Stent Thrombosis.</measure>
    <time_frame>9 months and 2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Polimeric-PES</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Arm receiving polimeric stent (Taxus)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Polimeric PES</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Arm receiving non-polimeric PES (axxion)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous transluminal Coronary Angioplasty</intervention_name>
    <description>Coronary artery stent implantation</description>
    <arm_group_label>Polimeric-PES</arm_group_label>
    <arm_group_label>Non-Polimeric PES</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with coronary artery stenosis in one, two or three vessels, and with
             objective evidence of isquemia.

          -  The stenosis must allow IVUS analisis, must be treatable with angioplasty with stent

          -  Target Vessel diameter must be between 2.25- 4 mm with QCA.

          -  Patients must sign informed consent

          -  Patients and their physician must accept the angiographic follow-up

        Exclusion Criteria:

          -  18 years old patients

          -  SCA within the last 72 hours, or patients with CK twice over the upper normal limit

          -  Pregnancy

          -  Target vessel diameter &lt; 2.25 or &gt; 4 mm by QCA

          -  Previous brakitherapy or DES in the target lesion

          -  Restenotic lesion

          -  -Allergy to aspirin, clopidogrel or ticlopidin

          -  Patients enrolled in other studies or trials

          -  By-pass graft lesions

          -  Real bifurcationa lesions

          -  Severe Renal insufficiency (creatinin clearance &lt; 30 ml/min).

          -  Severe Liver failure(GOT y GPT &gt; 3 times the upper normal limit)

          -  Life expectancy &lt; 1 year because of other pathologies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manel Sabate, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de la Santa Creu Y Sant Pau, Unidad de Hemodinamica</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Manel Sabate, MD, PhD</last_name>
    <phone>0034935565851</phone>
    <email>msabatet@santpau.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Clarissa Cola, MD</last_name>
    <phone>0034935565851</phone>
    <email>clarissacola@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital de la Santa Creu y Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manel sabate, MD, PhD</last_name>
      <phone>0034935565851</phone>
      <email>msabatet@santpau.es</email>
    </contact>
    <contact_backup>
      <last_name>Clarissa Cola, MD</last_name>
      <phone>0034935565851</phone>
      <email>clarissacola@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Manel Sabate, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Victoria Martin Yuste, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Clarissa Cola, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Hong MK, Mintz GS, Lee CW, Park DW, Lee SW, Kim YH, Kang DH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ. Impact of late drug-eluting stent malapposition on 3-year clinical events. J Am Coll Cardiol. 2007 Oct 9;50(15):1515-6. Epub 2007 Aug 27.</citation>
    <PMID>17919574</PMID>
  </reference>
  <verification_date>February 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 28, 2010</study_first_submitted>
  <study_first_submitted_qc>June 16, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2011</study_first_posted>
  <last_update_submitted>June 16, 2011</last_update_submitted>
  <last_update_submitted_qc>June 16, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 17, 2011</last_update_posted>
  <responsible_party>
    <name_title>Unitat de Hemodinàmic. Servei Cardiologia</name_title>
  </responsible_party>
  <keyword>Late stent malapposition</keyword>
  <keyword>stent thrombosis</keyword>
  <keyword>IVUS</keyword>
  <keyword>non-polimeric stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

